J H Laver
Overview
Explore the profile of J H Laver including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
262
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Krailo M, Goldman S, Slack R, Davenport V, Morris E, Laver J, et al.
Ann Oncol
. 2002 May;
13(3):460-9.
PMID: 11996479
Background: The outcome of children with relapsed Wilms' tumor is poor, especially with poor-risk factors such as unfavorable histology, early recurrence, previous three-drug therapy, relapse not confined to lungs and...
2.
Laver J, Mahmoud H, Pick T, Hutchinson R, Weinstein H, Schwenn M, et al.
Leuk Lymphoma
. 2001 Nov;
42(3):399-405.
PMID: 11699405
The Pediatric Oncology Group (POG) adopted a histology-based approach to the management of pediatric non-Hodgkin's lymphomas (NHL) utilizing the National Cancer Institute Working Formulation for Clinical Usage. Patients with diffuse...
3.
Ogawa M, Tajima F, Ito T, Sato T, Laver J, Deguchi T
Ann N Y Acad Sci
. 2001 Jul;
938:139-45.
PMID: 11458501
For more than a decade it was believed that hematopoietic stem cells express CD34. However, this dogma was recently challenged by the observation that stem cells of normal adult mice...
4.
Tajima F, Deguchi T, Laver J, Zeng H, Ogawa M
Blood
. 2001 Apr;
97(9):2618-24.
PMID: 11313250
The effects of activation of adult murine stem cells on their expression of CD38 were studied using a murine transplantation model. First, the published finding that the majority of long-term...
5.
Laver J, Hulsey T, Jones J, Gautreaux M, Barredo J, Abboud M
Biol Blood Marrow Transplant
. 2001 Feb;
7(1):45-8.
PMID: 11215698
African Americans have a lower registration rate for becoming potential bone marrow and stem cell donors. The same attitudes and behaviors are exhibited in regard to solid organ and blood...
6.
Tajima F, Sato T, Laver J, Ogawa M
Blood
. 2000 Aug;
96(5):1989-93.
PMID: 10961905
Controversy has existed about CD34 expression by hematopoietic stem cells. We recently reported that CD34 expression reflects the activation state of stem cells by using a murine transplantation model. It...
7.
Bennett C, Stinson T, Laver J, Bishop M, Godwin J, Tallman M
Leuk Lymphoma
. 2000 Mar;
37(1-2):65-70.
PMID: 10721770
Colony stimulating factors reduce the duration of neutropenia following intensive chemotherapy in a variety of settings, but the advantages in the management of leukemia are inconclusive. The variations in clinical...
8.
Laver J, Barredo J, Amylon M, Schwenn M, Kurtzberg J, Camitta B, et al.
Leukemia
. 2000 Mar;
14(3):369-73.
PMID: 10720128
Contemporary chemotherapy has significantly improved event-free survival among patients with T cell-lineage acute lymphoblastic leukemia (T-ALL). Unlike B-precursor ALL, most investigators are still using cranial radiation (CRT) and are hesitant...
9.
Bennett C, Stinson T, Lane D, Amylon M, Land V, Laver J
Med Pediatr Oncol
. 2000 Feb;
34(2):92-6.
PMID: 10657867
Background: Growth factor use has been shown to ameliorate chemotherapy-induced neutropenia, leading to shorter hospital stays and lower use of parenteral antibiotics, two costly areas of cancer treatment. Prior reports...
10.
Leibovitz E, Dagan R, Laver J, Piglansky L, Raiz S, Abboud M, et al.
Arch Dis Child
. 2000 Jan;
82(2):165-8.
PMID: 10648376
Objectives: To study the concentration of interleukin 8 (IL-8) in the middle ear fluid of children with acute otitis media and the association between IL-8 concentrations, aetiology of acute otitis...